Please login to the form below

Not currently logged in

Antares Pharma appoints LeRoux Jooste SVP pharma sales and marketing

Joins US self-injection and topical gel specialists from Cephalon

Cephalon's LeRoux Jooste has joined Antares Pharma as senior VP pharma sales and marketing.

He has experience in product planning and portfolio management in multiple therapeutic areas including endocrinology and rheumatology, and has worked with such products as Prozac, Ceclor and Gemzar during his 25-year career in healthcare.

“LeRoux brings to Antares a proven track record in leading sales and marketing organisations, launching new products and managing alliance partners,” said Dr Paul Wotton, president and CEO of Antares.

“In particular, LeRoux's experience working at Cephalon will be beneficial to Antares as we continue to grow this Company in an intelligent and focused way.”

During his time at biopharma Cephalon, LeRoux's most senior position was VP commercial assessment and new product planning, working his ways up from leadership positions in sales and marketing as well as commercial operations.

Previously, he was with Nabi Biopharmaceuticals as senior VP global sales and marketing after serving as chief operating officer of Aton Pharma.

Earlier in his career he held positions with Wyeth Pharmaceuticals and Eli Lilly & Company.

“The company is currently working to commercialize Vibex MTX and I'm looking forward to playing a pivotal role in that process,” said LeRoux.

“A successful launch will enable Antares to continue to build commercial capabilities for the recently announced Vibex QS T, potentially the first auto injector testosterone product for men suffering from symptomatic testosterone deficiency.”

16th May 2012


Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...